Citius Oncology (CTOR) Live Share Price, Invest From India

Citius Oncology Stock Performance

as on October 6, 2026 at 1:09 am IST

Day's Low
Day's High
$0.89
Day's Price Range
$0.92
$0.88
-1.14%
Downside
4.55%
Upside
52 Week's Low
52 Week's High
$0.49
52-Week Price Range
$2.25
$0.88
44.18%
Downside
155.68%
Upside

Citius Oncology share price movements today

Previous Close: $0.95
Open: $0.92
Volume: 54.1K
Market Cap: $100.5M
Day's Low - High: $0.89 - $0.92
52 Week Low - High: $0.49 - $2.25

Citius Oncology Historical Returns

1 Month Return: + 10.47 %
3 Month Return: + 39.62 %
1 Year Return: -49.74 %
3 Year Return: 0 %
5 Year Return: 0 %

Citius Oncology Stock Fundamentals & Key Indicators

Check Citius Oncology market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$100.5M

EPS (TTM)

-0.4777

Dividend Yield

0.00%

PE Ratio (TTM)

-1.99

Industry PE ratio

-7.45

PEG Ratio

0.05

Return On Equity TTM

-102.98%

Citius Oncology vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Citius Oncology with its industry peers.

Company	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin %	Dividend Yield %
Citius Oncology	NA	$100.5M	NA	-1.99	53.13%	0.00%
Sandoz Group Ltd Sponsored ADR	Buy	$36.3B	NA	55.49	47.54%	1.24%
United Therapeutics	Buy	$23.2B	186.99%	17.92	86.14%	0.00%
Viatris	Buy	$20.4B	29.41%	-48.81	34.83%	2.75%
Haleon PLC Sponsored ADR	Buy	$38.1B	NA	18.10	65.57%	2.25%

See all

Stock Returns calculator for Citius Oncology Stock including INR - Dollar returns

The Citius Oncology stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

Citius Oncology investment value today

Current value as on today

₹50,534

Returns

-₹49,466

(-49.47%)

Returns from Citius Oncology Stock

-₹53,439 (-53.44%)

Dollar Impact

₹3,974 (+3.97%)

Indian Investors' Interest in Citius Oncology Stock

Search interest for Citius Oncology Stock has decreased by -33% in the last 30 days, reflecting a downward trend in search activity.

Time period: September 5, 2026 to October 5, 2026

Change:-33% versus previous 30 day period

Citius Oncology Quarterly Profit & Loss

All numbers in Millions USD

	Mar 2024	Jun 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Total Revenue	-	-	-	-	-	-	-	3	1	1
Gross Profit	-	-	-	-	-	-	-	3	1	0
Operating Income	-4	-4	-6	-6	-7	-4	-4	-5	-28	-8
EBITDA	-4	-4	-6	-6	-7	-4	-4	-4	-26	-6
Interest Expense	-	-	-	-	-	0	0	0	0	0
Depreciation	-	-	-	-	-	-	-	0	-	1
Income Before Tax	-4	-4	-6	-6	-7	-5	-4	-5	-26	-9
Income Tax Expense	0	0	0	0	0	0	0	0	0	0
Net Income	-4	-4	-6	-6	-7	-5	-4	-5	-26	-8
Net Profit Margin	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	0.00%	79.99%	80.27%	-48.09%

Citius Oncology Annual Profit & Loss

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Total Revenue	-	-	-	-
Gross Profit	-	-	-	-
Operating Income	-9	-12	-20	-23
EBITDA	-	-12	-20	-23
Interest Expense	-	-	-	0
Depreciation	9	-	-	-
Income Before Tax	-9	-12	-20	-23
Income Tax Expense	1	0	0	1
Net Income	-10	-12	-21	-24
Net Profit Margin	0.00%	0.00%	0.00%	0.00%

Citius Oncology Quarterly Cash Flow

All numbers in Millions USD

	Mar 2024	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Net Income	0	-22	-6	-7	-5	-4	-5	-26	-8
Operating Cash Flow	0	0	-	-	-	-5	-7	-3	-2
Investing Cash Flow	24	-29	-	-	-	-5	-4	0	-2
Financing Cash Flow	-24	28	-	-	-	15	15	0	19
Change in Cash	0	0	0	-	-	3	3	-4	13

Citius Oncology Annual Cash Flow

All numbers in Millions USD

	Sep 2022	Sep 2023	Sep 2024	Sep 2025
Net Income	0	2	-21	-24
Operating Cash Flow	0	0	0	-5
Investing Cash Flow	-67	-1	-5	-5
Financing Cash Flow	67	1	4	15
Change in Cash	0	0	0	3

Global Institutional Holdings in Citius Oncology

Check out the Institutions with significant holdings in Citius Oncology.

Funds	Holdings
Vanguard	0.59%
VANGUARD INDEX FUNDS	0.58%
Fidelity Concord Street Trust	0.22%

Insights on Citius Oncology

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

NO EFFECT
Against Peers
In the last 1 year, Viatris Inc. Common Stock has given 72.7% return, outperforming this stock by 122.4%
NEGATIVE IMPACT
Price Dip
In the last 7 days, CTOR stock has moved down by -7.8%

About Citius Oncology

Citius Oncology, Inc. concentrates on advancing innovative, targeted therapeutic solutions for various cancer types. A key aspect of its pipeline includes the development of LYMPHIR, an investigational orphan drug intended to treat adults battling cutaneous T-cell lymphoma that has either relapsed or is unresponsive to existing therapies. The firm's main offices are situated in New York, New York. Citius Oncology, Inc. functions as a division of its parent company, Citius Pharmaceuticals, Inc.

Organisation	Citius Oncology
Headquarters	11 Commerce Drive, Cranford, NY, 07016, US
Industry	Medical - Pharmaceuticals
CEO	Leonard L. Mazur

Key Management of Citius Oncology

Name	Title
Mr. Myron Z. Holubiak	Secretary & Executive Vice Chairman
Dr. Myron S. Czuczman M.D.	Executive VP & Chief Medical Officer
Mr. Jaime Bartushak	CFO & Treasurer
Mr. Leonard L. Mazur	CEO, President & Executive Chairman

FAQs

What is Citius Oncology share price today?

Citius Oncology share price today is $0.88 as on October 5, 2026 at 7:39 pm IST. Citius Oncology share today touched a day high of $0.92 and a low of $0.89.

What is the 52 week high and 52 week low for Citius Oncology share?

Citius Oncology share touched a 52 week high of $2.25 on October 16, 2025 and a 52 week low of $0.49 on March 30, 2026. Citius Oncology stock price today i.e. October 5, 2026 at 7:39 pm IST is trending at $0.88,which is 60.89% down from its 52 week high and 79.15% up from its 52 week low.

What is Citius Oncology's market capitalisation today?

Citius Oncology market capitalisation is $0.00T as on October 5, 2026 at 7:39 pm IST.

How to invest in Citius Oncology Stock (CTOR) from India?

Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
Step 2: Search for Citius Oncology on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Citius Oncology Stock (CTOR) from India?

Indian investors can start investing in Citius Oncology (CTOR) shares with as little as ₹96.292503356934 or $1 (as of October 5, 2026 at 7:41 pm IST) using the INDmoney app.
For example: If you want to invest $10 or ₹962.93 in Citius Oncology stock (as per the Rupee-Dollar exchange rate as on October 5, 2026 at 7:41 pm IST). Based on Citius Oncology share’s latest price of $0.88 as on October 5, 2026 at 7:39 pm IST, you will get 11.3636 shares of Citius Oncology. Learn more about fractional shares .